caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1053386243

Hooshang MeshkinpourM.D.

Internal MedicineIrvine, CAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (1)

CCN 050348
Hospital
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
363
Unique beneficiaries
—
Total services
444
Distinct HCPCS
8
Medicare payment
$29K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 10,499 Internal Medicine providers in CA — below median (cohort median 531).
QUALITY · MIPS · 2024
Final MIPS score
100.0
Quality
83.7
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
1.05%
APM Entity
REFERRAL NETWORK

Where Hooshang Meshkinpour's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 5 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Unilab Corporation
Clinical Laboratory · West Hills, CA
1837
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
UNIVERSITY OF CALIFORNIA IRVINE69460
HOAG MEMORIAL HOSPITAL PRESBYTERIAN2141
Procedure Center Of Irvine Inc.
Ambulatory Surgical Center · Irvine, CA
2034
Unilab Corporation
Clinical Laboratory · West Hills, CA
1934
Laboratory Corporation Of America
Clinical Laboratory · San Diego, CA
1422
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
347
Beneficiaries
—
Total drug cost
$17K
Distinct drugs
5
Brand share
14.1%
Top prescribed drugs
Famotidine135 claims
Pantoprazole Sodium86 claims
Omeprazole77 claims
Sodium, Potassium,mag Sulfates32 claims
Linaclotide17 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$47
Payment records
1
By payment type
Food and Beverage$47
Top paying entities
Food and Beverage$47